CellTivity Scientific

About CellTivity Scientific

LLTech is a pioneering company in the medical technology sector, specializing in real-time biopsy evaluation. Originally known as LLTech, the company rebranded to Aqyre Biosciences in 2021 following a strategic shift and funding round. In 2025, Aqyre Biosciences underwent another rebranding and adopted its current name, CellTivity Scientific.

The company serves healthcare providers, including radiologists and surgeons, who require rapid and accurate biopsy assessments. Operating in the medical diagnostics market, CellTivity Scientific’s core product is a biopsy scanner that converts live tissue samples into data and digital images for expert review within two minutes. This technology addresses critical needs in radiology and surgery by significantly reducing the time required for biopsy assessments, which traditionally take up to two days, and minimizing the need for repeat procedures.

The business model is centered around selling and licensing its advanced biopsy scanners to medical institutions. Revenue is generated through direct sales, service contracts, and potential licensing agreements for its proprietary technology. CellTivity Scientific combines digital imaging with AI and machine learning to support physicians in swiftly and precisely identifying cancer cells and other critical indicators, making it a valuable partner in modern healthcare.